Navigation Links
A protein in the brain paves way for Alzheimer's treatment

Alzheimer's is the most common form of dementia in Canada, affecting some 5% of people over the age of 65. Statistics show that one in four people// over the age of 85 suffer from the disease. According to the study conducted by Dr. Peter St George-Hyslop who is a researcher working on Alzheimer's disease at the University of Toronto it is said that a single chemical in the brain is the cause of the disease. The researchers have discovered a substance in the brain that can stop Alzheimer's disease and could lead to a treatment for the degenerative disorder.

By using this discovery a new drug can be developed against the disease. Medicines that will stop the progressing of the disease and also those that will help to prevent the occurrence of the disease would soon be discovered. TPM21 is the protein that blocks the neurotoxin Abeta. This is known as beta-amyloid peptide, which is responsible for the onset of Alzheimer's. TPM21 blocks Abeta production without causing any side effects. But St George-Hyslop also cautioned that it has yet to be tested in animals and that a drug to mimic its antitoxin effects is likely at least five years away.

The crucial point is now to discover a small molecule that resembles and functions in the same way as this protein. Abeta-blocking compound would likely be used in conjunction with other therapies, such as a promising new Alzheimer's vaccine. Alzheimer's drug therapy would also require ongoing doses over a patient's lifetime. Dr. B. Lynn Beattie, chair of the research policy committee for the Alzheimer Society of Canada, cautioned that the disease has an enormously complex biochemistry and that this newly revealed protein represents just one step in the development of the disease.


Page: 1

Related medicine news :

1. Special proteins to fight TB identified
2. High-protein diets may pose health risks
3. Hidden influenza virus protein found
4. Special proteins to fight TB identified
5. Importance of soy protein in your diet
6. Unfavourable Lipid-Lipoprotein profiles in older adults has been linked to abdominal visceral fat
7. Stroke victims have new hope with activated protein C
8. Mental retardation linked to brain protein
9. HIV blocking protein in Monkey
10. Obese children may have abnormalities of lipoproteins
11. Artificially made protein to inhibit angiogenesis
Post Your Comments:

(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from reveals that behind the tendency to set low expectations is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... , June 26, 2016 One of Australia,s ... announced the formation of a new biotechnology company, Noxopharm Limited [ABN ... in an IPO and to list on the ASX. ... NOX66, ready to enter a Phase 1 clinical study later this ... to address one of the biggest problems facing cancer patients - ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology: